Nephros Inc. (NEPH) NASDAQ
$2.06 (0.07) (-3.29%)
Market Cap: $22.46M
As of 05/15/24 03:59 PM EDT. Market closed.
Nephros Inc. (NEPH)
NASDAQ
$2.06
(0.07) (-3.29%)
Market Cap: $22.46M
As of 05/15/24 03:59 PM EDT. Market closed.
Add to Portfolio
nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to ... read more
COMPANY PROFILE
Sector
Industry
PRICE CHART FOR NEPHROS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.18
Previous Close
$2.13
Days Range
$2.05 - $2.14
52 week range
$1.13 - $4.04
Volume
5,789
Avg. Volume (30 days)
12,811
Market Cap
$22.46M
Dividend Yield
-
P/E
-
Shares Outstanding
10,544,139
Open
$2.18
Previous Close
$2.13
Days Range
$2.05 - $2.14
52 week range
$1.13 - $4.04
Volume
5,789
Avg. Volume (30 days)
12,811
Market Cap
$22.46M
Dividend Yield
-
P/E
-
Shares Outstanding
10,544,139
FINANCIAL STATEMENTS FOR NEPHROS INC
LOADING...
INSIDER TRANSACTIONS FOR NEPHROS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Amron Arthur H | Director | Mar 12, 2024 | Buy | $2.45 | 7,000 | 17,130 | 7,000 | Mar 14, 2024, 04:28 PM |
Banks Robert R. Jr. | President and CEO | Dec 07, 2023 | Buy | $2.20 | 18,000 | 39,647 | 20,000 | Dec 11, 2023, 04:17 PM |
Banks Robert R. Jr. | President and CEO | Aug 15, 2023 | Buy | $1.69 | 1,901 | 3,207 | 2,000 | Aug 15, 2023, 04:15 PM |
Banks Robert R. Jr. | President and CEO | Aug 14, 2023 | Buy | $1.50 | 99 | 149 | 99 | Aug 15, 2023, 04:15 PM |
Astor Andrew | President, CEO & CFO | Mar 05, 2022 | Option Exercise | $2.70 | 14,815 | 40,001 | 92,773 | Mar 07, 2022, 05:44 PM |
Lobo Wesley S. | Chief Marketing Officer | Feb 16, 2022 | Option Exercise | $4.80 | 6,389 | 30,667 | 35,168 | Feb 18, 2022, 05:03 PM |
Lobo Wesley S. | Chief Marketing Officer | Aug 20, 2021 | Buy | $7.92 | 1,000 | 7,920 | 41,557 | Aug 23, 2021, 01:01 PM |
Gwydir Tom | Director | Aug 18, 2021 | Buy | $7.64 | 5,000 | 38,200 | 11,031 | Aug 19, 2021, 09:04 PM |
Astor Andrew | President & CEO | Aug 17, 2021 | Buy | $7.67 | 2,500 | 19,172 | 75,458 | Aug 18, 2021, 06:08 PM |
Astor Andrew | President & CEO | Aug 18, 2021 | Buy | $7.77 | 2,500 | 19,433 | 77,958 | Aug 18, 2021, 06:08 PM |
Evans Daron | CEO Specialty Renal Products | May 27, 2021 | Option Exercise | $2.70 | 349 | 942 | 8,669 | Jun 01, 2021, 05:39 PM |
Evans Daron | CEO Specialty Renal Products | May 27, 2021 | Option Exercise | $2.70 | 349 | 942 | 8,947 | Jun 01, 2021, 05:39 PM |
Evans Daron | CEO of Specialty Renal Product | May 24, 2021 | Option Exercise | $2.70 | 1,111 | 3,000 | 9,018 | May 25, 2021, 03:40 PM |
Evans Daron | CEO of Specialty Renal Product | May 24, 2021 | Option Exercise | $2.70 | 1,111 | 3,000 | 9,296 | May 25, 2021, 03:40 PM |
WEXFORD CAPITAL LP | Director | Jan 27, 2021 | Option Exercise | $4.22 | 14,754 | 62,260 | 106,037 | Jan 29, 2021, 04:49 PM |
Spandow Oliver J. | Director | Nov 18, 2020 | Buy | $5.83 | 1,500 | 8,749 | 15,734 | Nov 20, 2020, 04:28 PM |
Astor Andrew | President & CEO | Nov 19, 2020 | Buy | $5.87 | 1,000 | 5,867 | 72,958 | Nov 19, 2020, 06:17 PM |
WEXFORD CAPITAL LP | Director | Oct 15, 2020 | Option Exercise | $6.00 | 166,667 | 1,000,002 | 3,605,471 | Oct 16, 2020, 04:38 PM |
Astor Andrew | COO/CFO | Aug 19, 2020 | Buy | $7.40 | 950 | 7,030 | 71,958 | Aug 19, 2020, 06:22 PM |
Astor Andrew | CFO/COO | May 28, 2020 | Buy | $6.96 | 1,000 | 6,960 | 71,008 | May 29, 2020, 06:08 PM |
PERSEN MALCOLM C | Director | May 11, 2020 | Option Exercise | $7.65 | 1,732 | 13,250 | 5,194 | May 13, 2020, 04:56 PM |
Evans Daron | President and CEO | Mar 12, 2020 | Buy | $6.65 | 2,500 | 16,625 | 134,215 | Mar 12, 2020, 05:02 PM |
Astor Andrew | CFO/COO | Mar 12, 2020 | Buy | $6.70 | 1,000 | 6,700 | 70,008 | Mar 12, 2020, 04:50 PM |
Evans Daron | President and CEO | Mar 05, 2020 | Buy | $8.44 | 2,500 | 21,109 | 131,715 | Mar 05, 2020, 05:18 PM |
Astor Andrew | CFO/COO | Mar 05, 2020 | Buy | $8.46 | 700 | 5,920 | 69,008 | Mar 05, 2020, 05:10 PM |
Spandow Oliver J. | Director | Nov 25, 2019 | Buy | $8.17 | 1,000 | 8,170 | 10,786 | Nov 26, 2019, 04:25 PM |
Astor Andrew | CFO/COO | Nov 18, 2019 | Buy | $8.38 | 750 | 6,282 | 61,460 | Nov 18, 2019, 12:13 PM |
Evans Daron | President and CEO | Nov 18, 2019 | Buy | $8.35 | 1,000 | 8,350 | 119,933 | Nov 18, 2019, 12:12 PM |
Lask Alisa | Director | Sep 11, 2019 | Buy | $6.45 | 250 | 1,612 | 250 | Sep 13, 2019, 04:32 PM |
Astor Andrew | CFO/COO | Aug 22, 2019 | Buy | $6.97 | 1,500 | 10,455 | 60,710 | Aug 22, 2019, 04:37 PM |
Evans Daron | President and CEO | Aug 22, 2019 | Buy | $6.92 | 2,000 | 13,845 | 118,933 | Aug 22, 2019, 04:09 PM |
Astor Andrew | CFO/COO | Jun 14, 2019 | Buy | $0.64 | 35,000 | 22,400 | 532,903 | Jun 14, 2019, 12:35 PM |
Evans Daron | President and CEO | Jun 14, 2019 | Buy | $0.59 | 8,000 | 4,720 | 71,166 | Jun 14, 2019, 12:34 PM |
Evans Daron | President and CEO | Jun 14, 2019 | Buy | $0.58 | 8,000 | 4,653 | 73,666 | Jun 14, 2019, 12:34 PM |
Evans Daron | President and CEO | Jun 14, 2019 | Buy | $0.60 | 11,172 | 6,683 | 1,052,426 | Jun 14, 2019, 12:34 PM |
Evans Daron | President and CEO | Jun 14, 2019 | Buy | $0.60 | 8,000 | 4,830 | 8,000 | Jun 14, 2019, 12:34 PM |
Evans Daron | President and CEO | Jun 14, 2019 | Buy | $0.61 | 8,000 | 4,875 | 8,000 | Jun 14, 2019, 12:34 PM |
Astor Andrew | Chief Financial Officer | May 14, 2018 | Option Exercise | $0.30 | 33,333 | 10,000 | 453,792 | May 14, 2018, 04:44 PM |
Evans Daron | President and CEO | May 14, 2018 | Option Exercise | $0.30 | 40,000 | 12,000 | 95,000 | May 14, 2018, 07:27 AM |
Evans Daron | President and CEO | Apr 10, 2018 | Buy | $0.45 | 12,000 | 5,400 | 65,666 | Apr 12, 2018, 04:12 PM |
Evans Daron | President and CEO | Apr 10, 2018 | Buy | $0.45 | 55,000 | 24,750 | 55,000 | Apr 12, 2018, 04:12 PM |
Evans Daron | President and CEO | Apr 10, 2018 | Buy | $0.45 | 12,000 | 5,400 | 63,166 | Apr 12, 2018, 04:12 PM |
Astor Andrew | Chief Financial Officer | Apr 10, 2018 | Buy | $0.45 | 80,000 | 36,000 | 420,459 | Apr 12, 2018, 04:11 PM |
Astor Andrew | Chief Financial Officer | Mar 09, 2018 | Buy | $0.47 | 5,000 | 2,375 | 340,459 | Mar 13, 2018, 04:08 PM |
Astor Andrew | Chief Financial Officer | Dec 04, 2017 | Buy | $0.50 | 8,333 | 4,167 | 215,042 | Dec 05, 2017, 04:17 PM |
Astor Andrew | Chief Financial Officer | Dec 01, 2017 | Buy | $0.50 | 10,000 | 5,000 | 206,709 | Dec 05, 2017, 04:17 PM |
Evans Daron | President and CEO | Sep 06, 2017 | Buy | $0.24 | 28,000 | 6,818 | 712,958 | Sep 06, 2017, 05:13 PM |
Evans Daron | President and CEO | Sep 05, 2017 | Buy | $0.23 | 1,580 | 371 | 684,958 | Sep 06, 2017, 05:13 PM |
Astor Andrew | Chief Financial Officer | Jun 16, 2017 | Option Exercise | $0.26 | 43 | 11 | 186,709 | Aug 28, 2017, 04:53 PM |
Astor Andrew | Chief Financial Officer | Aug 28, 2017 | Buy | $0.27 | 10,000 | 2,712 | 196,709 | Aug 28, 2017, 04:53 PM |
Evans Daron | President and CEO | Aug 22, 2017 | Buy | $0.25 | 2,000 | 500 | 51,166 | Aug 23, 2017, 12:51 PM |
Evans Daron | President and CEO | Aug 22, 2017 | Buy | $0.25 | 2,000 | 500 | 53,666 | Aug 23, 2017, 12:51 PM |
Evans Daron | President and CEO | Aug 11, 2017 | Buy | $0.26 | 70,000 | 18,200 | 683,378 | Aug 11, 2017, 05:35 PM |
Astor Andrew | Chief Financial Officer | Aug 11, 2017 | Buy | $0.26 | 20,000 | 5,198 | 186,666 | Aug 11, 2017, 05:35 PM |
Evans Daron | President and CEO | Jun 09, 2017 | Buy | $0.26 | 7,500 | 1,950 | 49,166 | Jun 13, 2017, 04:19 PM |
Evans Daron | President and CEO | Jun 09, 2017 | Buy | $0.26 | 10,000 | 2,600 | 51,666 | Jun 13, 2017, 04:19 PM |
Evans Daron | President and CEO | Jun 12, 2017 | Buy | $0.26 | 3,961 | 1,030 | 613,378 | Jun 13, 2017, 04:19 PM |
Evans Daron | President and CEO | May 19, 2017 | Buy | $0.25 | 7,500 | 1,912 | 609,417 | May 19, 2017, 05:55 PM |
Evans Daron | President and CEO | May 18, 2017 | Buy | $0.25 | 22,500 | 5,737 | 601,917 | May 19, 2017, 05:55 PM |
Evans Daron | President and CEO | Dec 07, 2016 | Buy | $0.32 | 4,069 | 1,302 | 339,428 | Dec 09, 2016, 05:11 PM |
Evans Daron | President and CEO | Dec 05, 2016 | Buy | $0.34 | 10,620 | 3,610 | 335,359 | Dec 06, 2016, 04:37 PM |
Evans Daron | President and CEO | Dec 01, 2016 | Buy | $0.32 | 40,599 | 13,016 | 324,739 | Dec 02, 2016, 04:28 PM |
Evans Daron | President and CEO | Nov 30, 2016 | Buy | $0.29 | 931 | 270 | 284,140 | Dec 02, 2016, 04:28 PM |
Evans Daron | President and CEO | Aug 27, 2015 | Buy | $0.56 | 19,175 | 10,738 | 144,759 | Aug 31, 2015, 04:24 PM |
Evans Daron | President and CEO | Aug 31, 2015 | Buy | $0.57 | 10,000 | 5,700 | 169,759 | Aug 31, 2015, 04:24 PM |
Evans Daron | President and CEO | Aug 28, 2015 | Buy | $0.59 | 15,000 | 8,900 | 159,759 | Aug 31, 2015, 04:24 PM |
Evans Daron | President and CEO | Aug 20, 2015 | Buy | $0.56 | 27,000 | 15,120 | 125,584 | Aug 20, 2015, 06:43 PM |
Evans Daron | President and CEO | Aug 19, 2015 | Buy | $0.50 | 24,500 | 12,250 | 98,584 | Aug 20, 2015, 06:43 PM |
CENTELLA LAWRENCE J | Director | Dec 18, 2014 | Option Exercise | $0.60 | 10,202 | 6,121 | 121,332 | Dec 22, 2014, 06:39 PM |
ROSENBERG MATTHEW | Director | Dec 18, 2014 | Option Exercise | $0.60 | 374,997 | 224,998 | 589,695 | Dec 22, 2014, 05:57 PM |
Houghton John C. | President, CEO and Acting CFO | Dec 18, 2014 | Option Exercise | $0.60 | 7,885 | 4,731 | 74,139 | Dec 22, 2014, 05:56 PM |
Evans Daron | Director | Dec 18, 2014 | Option Exercise | $0.60 | 21,239 | 12,743 | 74,084 | Dec 22, 2014, 05:53 PM |
Evans Daron | Director | Mar 21, 2014 | Option Exercise | $0.30 | 2,151 | 645 | 9,651 | Mar 27, 2014, 04:45 PM |
CENTELLA LAWRENCE J | Director | Mar 21, 2014 | Option Exercise | $0.30 | 19,105 | 5,732 | 85,735 | Mar 24, 2014, 05:22 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Amron Arthur H | Director | 03/12/2024 | 17,130 |
Banks Robert R. Jr. | President and CEO | 12/07/2023 | 39,647 |
Banks Robert R. Jr. | President and CEO | 08/15/2023 | 3,207 |
Banks Robert R. Jr. | President and CEO | 08/14/2023 | 149 |
Astor Andrew | President, CEO & CFO | 03/05/2022 | 40,001 |
Lobo Wesley S. | Chief Marketing Officer | 02/16/2022 | 30,667 |
Lobo Wesley S. | Chief Marketing Officer | 08/20/2021 | 7,920 |
Gwydir Tom | Director | 08/18/2021 | 38,200 |
Astor Andrew | President & CEO | 08/17/2021 | 19,172 |
Astor Andrew | President & CEO | 08/18/2021 | 19,433 |
Evans Daron | CEO Specialty Renal Products | 05/27/2021 | 942 |
Evans Daron | CEO Specialty Renal Products | 05/27/2021 | 942 |
Evans Daron | CEO of Specialty Renal Product | 05/24/2021 | 3,000 |
Evans Daron | CEO of Specialty Renal Product | 05/24/2021 | 3,000 |
WEXFORD CAPITAL LP | Director | 01/27/2021 | 62,260 |
Spandow Oliver J. | Director | 11/18/2020 | 8,749 |
Astor Andrew | President & CEO | 11/19/2020 | 5,867 |
WEXFORD CAPITAL LP | Director | 10/15/2020 | 1,000,002 |
Astor Andrew | COO/CFO | 08/19/2020 | 7,030 |
Astor Andrew | CFO/COO | 05/28/2020 | 6,960 |
PERSEN MALCOLM C | Director | 05/11/2020 | 13,250 |
Evans Daron | President and CEO | 03/12/2020 | 16,625 |
Astor Andrew | CFO/COO | 03/12/2020 | 6,700 |
Evans Daron | President and CEO | 03/05/2020 | 21,109 |
Astor Andrew | CFO/COO | 03/05/2020 | 5,920 |
Spandow Oliver J. | Director | 11/25/2019 | 8,170 |
Astor Andrew | CFO/COO | 11/18/2019 | 6,282 |
Evans Daron | President and CEO | 11/18/2019 | 8,350 |
Lask Alisa | Director | 09/11/2019 | 1,612 |
Astor Andrew | CFO/COO | 08/22/2019 | 10,455 |
Evans Daron | President and CEO | 08/22/2019 | 13,845 |
Astor Andrew | CFO/COO | 06/14/2019 | 22,400 |
Evans Daron | President and CEO | 06/14/2019 | 4,720 |
Evans Daron | President and CEO | 06/14/2019 | 4,653 |
Evans Daron | President and CEO | 06/14/2019 | 6,683 |
Evans Daron | President and CEO | 06/14/2019 | 4,830 |
Evans Daron | President and CEO | 06/14/2019 | 4,875 |
Astor Andrew | Chief Financial Officer | 05/14/2018 | 10,000 |
Evans Daron | President and CEO | 05/14/2018 | 12,000 |
Evans Daron | President and CEO | 04/10/2018 | 5,400 |
Evans Daron | President and CEO | 04/10/2018 | 24,750 |
Evans Daron | President and CEO | 04/10/2018 | 5,400 |
Astor Andrew | Chief Financial Officer | 04/10/2018 | 36,000 |
Astor Andrew | Chief Financial Officer | 03/09/2018 | 2,375 |
Astor Andrew | Chief Financial Officer | 12/04/2017 | 4,167 |
Astor Andrew | Chief Financial Officer | 12/01/2017 | 5,000 |
Evans Daron | President and CEO | 09/06/2017 | 6,818 |
Evans Daron | President and CEO | 09/05/2017 | 371 |
Astor Andrew | Chief Financial Officer | 06/16/2017 | 11 |
Astor Andrew | Chief Financial Officer | 08/28/2017 | 2,712 |
Evans Daron | President and CEO | 08/22/2017 | 500 |
Evans Daron | President and CEO | 08/22/2017 | 500 |
Evans Daron | President and CEO | 08/11/2017 | 18,200 |
Astor Andrew | Chief Financial Officer | 08/11/2017 | 5,198 |
Evans Daron | President and CEO | 06/09/2017 | 1,950 |
Evans Daron | President and CEO | 06/09/2017 | 2,600 |
Evans Daron | President and CEO | 06/12/2017 | 1,030 |
Evans Daron | President and CEO | 05/19/2017 | 1,912 |
Evans Daron | President and CEO | 05/18/2017 | 5,737 |
Evans Daron | President and CEO | 12/07/2016 | 1,302 |
Evans Daron | President and CEO | 12/05/2016 | 3,610 |
Evans Daron | President and CEO | 12/01/2016 | 13,016 |
Evans Daron | President and CEO | 11/30/2016 | 270 |
Evans Daron | President and CEO | 08/27/2015 | 10,738 |
Evans Daron | President and CEO | 08/31/2015 | 5,700 |
Evans Daron | President and CEO | 08/28/2015 | 8,900 |
Evans Daron | President and CEO | 08/20/2015 | 15,120 |
Evans Daron | President and CEO | 08/19/2015 | 12,250 |
CENTELLA LAWRENCE J | Director | 12/18/2014 | 6,121 |
ROSENBERG MATTHEW | Director | 12/18/2014 | 224,998 |
Houghton John C. | President, CEO and Acting CFO | 12/18/2014 | 4,731 |
Evans Daron | Director | 12/18/2014 | 12,743 |
Evans Daron | Director | 03/21/2014 | 645 |
CENTELLA LAWRENCE J | Director | 03/21/2014 | 5,732 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NEPHROS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 71,037 | 0.00001% | No change | Other |
RENAISSANCE TECHNOLOGIES LLC | 41,200 | 0.00014% | New | Other |
BLACKROCK INC. | 4,131 | 0% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR NEPHROS INC
STOCK BUYBACKS FOR NEPHROS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.26%
1Q
06/30/2023
1.85%
2Q
03/31/2023
1.85%
3Q
12/31/2022
1.29%
4Q
09/30/2022
1.79%
5Q
06/30/2022
1.83%
6Q
03/31/2022
2.68%
7Q
12/31/2021
2.83%
8Q
09/30/2021
4.41%
9Q
06/30/2021
5.48%
10Q
03/31/2021
6.12%
11Q
12/31/2020
8.16%
12Q
09/30/2020
16.02%
13Q
06/30/2020
16.71%
14Q
03/31/2020
22.09%
15Q
12/31/2019
32.03%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEPHROS INC
LOADING...